Relationship Between Morbimortality and Basal Activated Clotting Time (ACT) in Patients Undergoing Vascular Surgery

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04703582

Enrollment

Registered

2021-01-11

Start date

2021-01-31

Completion date

2021-06-30

Last updated

2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Diseases, Artery Disease, Peripheral, Carotid Artery Diseases, Other Disease

Brief summary

Check whether patients with higher comorbidity and risk of complication, estimated using the V (p) -POSSUM score, ACS NSQIP and the ASA classification, present higher baseline activated clotting time values.

Interventions

DIAGNOSTIC_TESTActivated clotting time

Relationship between elongated baseline activated clotting time and comorbidity

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients undergoing vascular surgery requiring intraoperative heparinization

Exclusion criteria

* Pregnant women * SARS-CoV-2 PCR positive (performed 24-72h prior to surgery) * Severe plaquetopenia \<50,000

Design outcomes

Primary

Measure	Time frame	Description
Change on baseline Activated Clotting Time with comorbidities	1 day - surgery day	Activted Clotting Time will be measured with Haemocron Machine just before surgery. Comorbidities will be measured with V(p)Possum, AC NSQUIP and ASA scales.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026